Ivana Jovčevska

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 18

Top Topics

Long Noncoding Rna

Top Venues

International journal of molecular sciences

Therapeutic advances in medical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Nives Pećina-Šlaus, Ivana Jovčevska
Different Approaches to Study Molecular Blueprint and Biological Behavior of Brain Tumors: Editorial to the Special Issue "Advances in Molecular Genetics of Brain Tumors". International journal of molecular sciences 24 (2) (2023)
Nives Pećina-Šlaus, Ivana Jovčevska
Different Approaches to Study Molecular Blueprint and Biological Behavior of Brain Tumors: Editorial to the Special Issue "Advances in Molecular Genetics of Brain Tumors". International journal of molecular sciences 24 (2) (2023)
Alja Zottel, Metka Novak, Neja Šamec, Bernarda Majc, Sara Colja, Mojca Katrašnik, Miloš Vittori, Barbara Hrastar, Ana Rotter, Andrej Porčnik, Tamara Lah Turnšek, Radovan Komel, Barbara Breznik, Ivana Jovčevska
Anti-Vimentin Nanobody Decreases Glioblastoma Cell Invasion In Vitro and In Vivo. Cancers 15 (3) (2023)
Nives Pećina-Šlaus, Ivana Jovčevska
Different Approaches to Study Molecular Blueprint and Biological Behavior of Brain Tumors: Editorial to the Special Issue "Advances in Molecular Genetics of Brain Tumors". International journal of molecular sciences 24 (2) (2023)
Nives Pećina-Šlaus, Ivana Jovčevska
Different Approaches to Study Molecular Blueprint and Biological Behavior of Brain Tumors: Editorial to the Special Issue "Advances in Molecular Genetics of Brain Tumors". International journal of molecular sciences 24 (2) (2023)
Alja Zottel, Metka Novak, Neja Šamec, Bernarda Majc, Sara Colja, Mojca Katrašnik, Miloš Vittori, Barbara Hrastar, Ana Rotter, Andrej Porčnik, Tamara Lah Turnšek, Radovan Komel, Barbara Breznik, Ivana Jovčevska
Anti-Vimentin Nanobody Decreases Glioblastoma Cell Invasion In Vitro and In Vivo. Cancers 15 (3) (2023)
Gloria Krapež, Katarina Kouter, Ivana Jovčevska, Alja Videtič Paska
Dynamic Intercell Communication between Glioblastoma and Microenvironment through Extracellular Vesicles. Biomedicines 10 (1) (2022)
Maria Victoria Martinez-Dominguez, Alja Zottel, Neja Šamec, Ivana Jovčevska, Can Dincer, Ulf Dietrich Kahlert, Ann-Christin Nickel
Current Technologies for RNA-Directed Liquid Diagnostics. Cancers 13 (20) (2021)
Andrej Porčnik, Metka Novak, Barbara Breznik, Bernarda Majc, Barbara Hrastar, Neja Šamec, Alja Zottel, Ivana Jovčevska, Miloš Vittori, Ana Rotter, Radovan Komel, Tamara Lah Turnšek
TRIM28 Selective Nanobody Reduces Glioblastoma Stem Cell Invasion. Molecules (Basel, Switzerland) 26 (17) (2021)
Maxim Sorokin, Mikhail Raevskiy, Alja Zottel, Neja Šamec, Marija Skoblar Vidmar, Alenka Matjašič, Andrej Zupan, Jernej Mlakar, Maria Suntsova, Denis V Kuzmin, Anton Buzdin, Ivana Jovčevska
Large-Scale Transcriptomics-Driven Approach Revealed Overexpression of CRNDE as a Poor Survival Prognosis Biomarker in Glioblastoma. Cancers 13 (14) (2021)
Šimen Ravnik, Ines Žabkar, Uršula Prosenc Zmrzljak, Ivana Jovčevska, Neja Šamec, Miha Moškon, Alja Videtič Paska
OligoPrime: An Information System for Oligonucleotide Management. Biomedical engineering and computational biology 12 (2021)
Marianna A Zolotovskaia, Victor Tkachev, Maxim Sorokin, Andrew Garazha, Ella Kim, Sven Rainer Kantelhardt, Sven-Ernö Bikar, Alja Zottel, Neja Šamec, Denis Kuzmin, Bettina Sprang, Alexey Moisseev, Alf Giese, Victor Efimov, Ivana Jovčevska, Anton Buzdin
Algorithmically Deduced FREM2 Molecular Pathway Is a Potent Grade and Survival Biomarker of Human Gliomas. Cancers 13 (16) (2021)
Alja Zottel, Neja Šamec, Ana Kump, Lucija Raspor Raspor Dall'Olio, Pia Pužar Dominkuš, Rok Romih, Samo Hudoklin, Jernej Mlakar, Daniil Nikitin, Maxim Sorokin, Anton Buzdin, Ivana Jovčevska, Radovan Komel
Analysis of miR-9-5p, miR-124-3p, miR-21-5p, miR-138-5p, and miR-1-3p in Glioblastoma Cell Lines and Extracellular Vesicles. International journal of molecular sciences 21 (22) (2020)
Alja Zottel, Ivana Jovčevska, Neja Šamec, Jernej Mlakar, Jernej Šribar, Igor Križaj, Marija Skoblar Vidmar, Radovan Komel
Anti-vimentin, anti-TUFM, anti-NAP1L1 and anti-DPYSL2 nanobodies display cytotoxic effect and reduce glioblastoma cell migration. Therapeutic advances in medical oncology 12 (2020)
Alja Zottel, Neja Šamec, Alja Videtič Paska, Ivana Jovčevska
Coding of Glioblastoma Progression and Therapy Resistance through Long Noncoding RNAs. Cancers 12 (7) (2020)
Alja Zottel, Alja Videtič Paska, Ivana Jovčevska
Nanotechnology Meets Oncology: Nanomaterials in Brain Cancer Research, Diagnosis and Therapy. Materials (Basel, Switzerland) 12 (10) (2019)
Ivana Jovčevska, Alja Zottel, Neja Šamec, Jernej Mlakar, Maxim Sorokin, Daniil Nikitin, Anton A Buzdin, Radovan Komel
High FREM2 Gene and Protein Expression Are Associated with Favorable Prognosis of IDH-WT Glioblastomas. Cancers 11 (8) (2019)
Ivana Jovčevska
Sequencing the next generation of glioblastomas. Critical reviews in clinical laboratory sciences 55 (4) (2018)